Our group and others have demonstrated that activation of innate immune pathways in cancer cells, such as canonical cGAS/STING signaling [5], is a good predictor of antitumor immune response [3] and that exceptionally long R LC patients may harbor germline variants in DDR genes [8]. The gene discussed is STING1; the disease is cancer.